TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33877002

Group type: EXPERIMENTAL
Intervention: Larger disc area
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased neuroretinal rim volume
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thicker RNFL
Number of subjects: 0
Study: 33847150

Group type: EXPERIMENTAL
Intervention: Qigong intervention for 6 weeks
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Qigong intervention
Number of subjects: 156

Group type: COMPARATOR
Intervention: Waitlist control group receiving usual care
Number of subjects: 156
Study: 32761176

Group type: COMPARATOR
Intervention: Routine health facility data (API)
Number of subjects: 5580

Group type: EXPERIMENTAL
Intervention: Serological measures (gold-standard)
Number of subjects: 5580
Study: 36299880

Group type: EXPERIMENTAL
Intervention: Kunbixiao granule (KBXG)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 32423331

Group type: EXPERIMENTAL
Intervention: Calcitonin gene‐related peptide
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 26
Study: 34962008

Group type: EXPERIMENTAL
Intervention: Early skin-to-skin contact
Number of subjects: 241

Group type: COMPARATOR
Intervention: Traditional neonatal care
Number of subjects: 241
Study: 33675044

Group type: EXPERIMENTAL
Intervention: Papaverine
Number of subjects: 498

Group type: COMPARATOR
Intervention: Control
Number of subjects: 498
Study: 32215467

Group type: EXPERIMENTAL
Intervention: Intervention Group received printed guidelines and a demonstration and training session with a physical therapist in a simulated environment.
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control Group received only printed guidelines regarding the postoperative period.
Number of subjects: 68
Study: 35157551

Group type: EXPERIMENTAL
Intervention: Self-affirmation (n=43)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (n=45)
Number of subjects: 88
Study: 33256485

Group type: EXPERIMENTAL
Intervention: Ready-made spectacles available programme
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Custom-made spectacles only programme
Number of subjects: 1000
Study: 616625220

Group type: EXPERIMENTAL
Intervention: EOAP regimen combined with Chansu injection (20 ml/d, intravenous drip, on d 1-14)
Number of subjects: 65

Group type: COMPARATOR
Intervention: EOAP regimen alone
Number of subjects: 65
Study: 34479999

Group type: EXPERIMENTAL
Intervention: Interacting groups solving complex tasks
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Interacting groups solving simpler tasks
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Interacting groups
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Independent individuals
Number of subjects: 1200
Study: 32628359

Group type: EXPERIMENTAL
Intervention: SCO-101
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 35926260

Group type: EXPERIMENTAL
Intervention: Board game play (experimental group, n=35)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Didactic lecture (comparison group, n=34)
Number of subjects: 69
Study: 32334635

Group type: COMPARATOR
Intervention: Clinical model
Number of subjects: 390

Group type: COMPARATOR
Intervention: Patient-demographic model
Number of subjects: 390

Group type: COMPARATOR
Intervention: Radiomic-derived model
Number of subjects: 390
Study: 34991359

Group type: EXPERIMENTAL
Intervention: Negative binomial regression
Number of subjects: 0
Study: 32022827

Group type: EXPERIMENTAL
Intervention: Risk reduction through family therapy (RRFT)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 124
Study: 34448546

Group type: EXPERIMENTAL
Intervention: Partnership Care Model (PCM)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 67
Study: 32986655

Group type: EXPERIMENTAL
Intervention: Pilates exercise group (n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (n=20)
Number of subjects: 40
Study: 32808345

Group type: EXPERIMENTAL
Intervention: Freestyle swim training (8 weeks, 3 times a week, 30 min per session, increased to 40 min after 4 weeks)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 26
Study: 36253078

Group type: EXPERIMENTAL
Intervention: Generalized estimating equations (GEE) analysis for complete and incomplete stepped wedge designs
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Analytical power method
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Estimation using the correctly specified model-based variance estimator
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Fast GEE power method
Number of subjects: 6
Study: 33694358

Group type: EXPERIMENTAL
Intervention: taVNS (15 min)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: OA-D (5 min followed by 10 min rest)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (no intervention for 15 min)
Number of subjects: 27
Study: 33451978

Group type: COMPARATOR
Intervention: Sipuleucel-T
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Radium-223 + Sipuleucel-T
Number of subjects: 32
Study: 32454417

Group type: EXPERIMENTAL
Intervention: Cisplatin (100 mg/m2/day on days 1, 22 and 43 of radiotherapy)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Cetuximab (400 mg/m2 loading dose, 250 mg/m2/week during radiotherapy)
Number of subjects: 116
Study: 35186114

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 µg/kg before skin incision for 10 min, followed by intravenous infusion at 0.4 µg·kg‐1·h‐1 until 30 min before surgery.
Number of subjects: 70

Group type: COMPARATOR
Intervention: Normal saline before skin resection (control group).
Number of subjects: 70
Study: 33788154

Group type: EXPERIMENTAL
Intervention: SUVN-D4010 (25 mg single dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SUVN-D4010 (up to 45 mg single dose and up to 40 mg once daily for 14 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: SUVN-D4010 (fed vs fasted state)
Number of subjects: 0
Study: 35030564

Group type: EXPERIMENTAL
Intervention: High-value elements (HVE) intervention
Number of subjects: 16099

Group type: COMPARATOR
Intervention: Quality improvement goals (control)
Number of subjects: 16099
Study: 34672064

Group type: EXPERIMENTAL
Intervention: 0.33% hydrocortisone sodium phosphate solution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.001% hydrocortisone sodium phosphate solution
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 0
Study: 35243305

Group type: EXPERIMENTAL
Intervention: Direction and angle marking on forearm skin (intervention group)
Number of subjects: 83

Group type: COMPARATOR
Intervention: No structured cannulation information system (control group)
Number of subjects: 83
Study: 35724496

Group type: EXPERIMENTAL
Intervention: Cognitive remediation (CR) plus treatment-as-usual (TAU)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 80
Study: 32162448

Group type: EXPERIMENTAL
Intervention: Carbohydrate-rich drink
Number of subjects: 16

Group type: COMPARATOR
Intervention: 5% glucose solution
Number of subjects: 16
Study: 35907781

Group type: EXPERIMENTAL
Intervention: Yokukansan (TJ-54)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study: 34850657

Group type: EXPERIMENTAL
Intervention: Oseltamivir treatment
Number of subjects: 277
Study: 35477377

Group type: EXPERIMENTAL
Intervention: Low-dose intrathecal morphine (100 µg) with 12.5 mg of 0.5% hyperbaric bupivacaine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sufentanil PCIA (100 µg) with 12.5 mg of 0.5% hyperbaric bupivacaine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Low-dose intrathecal morphine (100 µg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sufentanil PCIA (100 µg)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 32001481

Group type: EXPERIMENTAL
Intervention: Atezolizumab plus paclitaxel protein-bound
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus paclitaxel protein-bound
Number of subjects: 0
Study: 35314926

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham treatment (control)
Number of subjects: 32
Study: 32134961

Group type: EXPERIMENTAL
Intervention: Paternal involvement
Number of subjects: 104
Study: 35405011

Group type: EXPERIMENTAL
Intervention: Once-weekly somatrogon (0.66 mg/kg/week)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Once-daily somatropin (0.24 mg/kg/week)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Once-weekly somatrogon
Number of subjects: 228
Study: 34476342

Group type: EXPERIMENTAL
Intervention: Calcium (1000 mg) plus Vitamin D (400 IU) supplementation
Number of subjects: 36282

Group type: EXPERIMENTAL
Intervention: Calcium (1000 mg) plus Vitamin D (400 IU) supplementation with personal supplements
Number of subjects: 36282

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36282
Study: 32065769

Group type: EXPERIMENTAL
Intervention: Linear Exercise Training (LET)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Nonlinear Exercise Training (NLET)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Attention Control (Stretching)
Number of subjects: 174
Study: 35316819

Group type: EXPERIMENTAL
Intervention: Nerve Growth Factor (NGF) injection
Number of subjects: 40

Group type: COMPARATOR
Intervention: Isotonic saline (control)
Number of subjects: 40
Study: 32044905

Group type: EXPERIMENTAL
Intervention: Fish oil (FO, n = 38, 2 g day‐1 EPA + DHA)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control corn oil (CO, n = 39)
Number of subjects: 77
Study: 32777896

Group type: EXPERIMENTAL
Intervention: Intravenous oxycodone (0.1 mg kg–1) administered 20 min before intubation
Number of subjects: 6
Study: 33401232

Group type: EXPERIMENTAL
Intervention: Mobilization with movement (MWM)
Number of subjects: 32
Study: 35974309

Group type: COMPARATOR
Intervention: alfentanil and propofol (AP) group
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: alfentanil and remimazolam 0.1 mg/kg (AR1 group)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: alfentanil and remimazolam 0.15 mg/kg (AR2 group)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: alfentanil and remimazolam 0.2 mg/kg (AR3 group)
Number of subjects: 120
Study: 34106250

Group type: EXPERIMENTAL
Intervention: Anodal tDCS under placebo medication
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS under placebo medication
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Anodal tDCS under citalopram (20 mg/40 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS under citalopram (40 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS under citalopram (20 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo medication
Number of subjects: 12
Study: 34982507

Group type: EXPERIMENTAL
Intervention: DA‐5520 with laser resurfacing (test 1)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: DA‐5520 with comedone extraction (test 2)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Moisturizers alone (control 1)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Moisturizers alone (control 2)
Number of subjects: 36
Study: 33772124

Group type: EXPERIMENTAL
Intervention: Active intervention group (AG) with multiple interventions including training courses for nurses on dental health, oral health-related information cards (OHICs), and atraumatic restorative treatment (ART)-trained dentists
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: Passive intervention group (PG) implementing OHICs and ART-trained dentists
Number of subjects: 368

Group type: COMPARATOR
Intervention: Control group (CG) receiving a 45-minute lecture on oral health
Number of subjects: 368
Study: 35902950

Group type: EXPERIMENTAL
Intervention: Nomogram prediction model based on risk factors (gender, primary diagnosis, postoperative residual pain, poor postoperative range of motion, wound healing, rate of change in HKA)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Nomogram prediction model
Number of subjects: 208
Study: 34990170

Group type: EXPERIMENTAL
Intervention: Supportive Leadership Training (SLT)
Number of subjects: 496
Study: 32449254

Group type: EXPERIMENTAL
Intervention: Baloxavir
Number of subjects: 5
Study: 34511016

Group type: EXPERIMENTAL
Intervention: dCBT-I
Number of subjects: 208

Group type: COMPARATOR
Intervention: sleep education
Number of subjects: 208
Study: 33357246

Group type: EXPERIMENTAL
Intervention: Pre-operative physical activity
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: Post-operative physical activity
Number of subjects: 640

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 640
Study: 34747807

Group type: EXPERIMENTAL
Intervention: MIRE therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 30
Study: 32766852

Group type: EXPERIMENTAL
Intervention: Intensified chemotherapy for CNS+ patients in the international randomized phase 3 trial Inter-B-NHL-ritux 2010
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide, oncovin (vincristine), prednisone prephase
Number of subjects: 217
Study: 33908815

Group type: EXPERIMENTAL
Intervention: Luteinising hormone (LH) supplementation (Group A)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group without LH supplementation (Group B)
Number of subjects: 0
Study: 33753034

Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve implantation (TAVI)
Number of subjects: 3663

Group type: COMPARATOR
Intervention: Medically managed patients
Number of subjects: 3663
Study: 32815648

Group type: EXPERIMENTAL
Intervention: HERB system + standard lifestyle modification
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard lifestyle modification alone
Number of subjects: 0
Study: 36302195

Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Awake prone positioning
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen paired with awake prone positioning
Number of subjects: 0
Study: 33823974

Group type: EXPERIMENTAL
Intervention: SBIRT intervention
Number of subjects: 791

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 791
Study: 34387826

Group type: EXPERIMENTAL
Intervention: High Flow Nasal Oxygen (HFNO)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional Oxygen Therapy
Number of subjects: 50
Study: 35367279

Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) 800 mg
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 33761149

Group type: EXPERIMENTAL
Intervention: Cytisine
Number of subjects: 679

Group type: COMPARATOR
Intervention: Varenicline
Number of subjects: 679
Study: 32339504

Group type: EXPERIMENTAL
Intervention: Off-pump CABG
Number of subjects: 349

Group type: COMPARATOR
Intervention: On-pump CABG
Number of subjects: 349
Study: 35197331

Group type: EXPERIMENTAL
Intervention: Tailored 2-day educational course on skin cancer management
Number of subjects: 54
Study: 34979245

Group type: COMPARATOR
Intervention: High-Definition White Light Colonoscopy (HDWLE)
Number of subjects: 1203

Group type: EXPERIMENTAL
Intervention: Cuff (CF) (Endocuff Vision)
Number of subjects: 1203

Group type: EXPERIMENTAL
Intervention: Cap (CP) (Reveal)
Number of subjects: 1203
Study: 32756922

Group type: EXPERIMENTAL
Intervention: PXS group
Number of subjects: 38

Group type: COMPARATOR
Intervention: Non-PXS group
Number of subjects: 38
Study: 33367925

Group type: EXPERIMENTAL
Intervention: Stretching for 60 seconds
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Stretching for 30 seconds
Number of subjects: 100

Group type: COMPARATOR
Intervention: Stretching for 15 seconds
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no stretch)
Number of subjects: 100
Study: 32485734

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33002752

Group type: EXPERIMENTAL
Intervention: Rotator interval approach in-plane
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Rotator interval approach out-of-plane
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Posterior approach in-plane
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Posterior approach out-of-plane
Number of subjects: 120

Group type: COMPARATOR
Intervention: Posterior glenohumeral approach
Number of subjects: 120
Study: 32876405

Group type: COMPARATOR
Intervention: Clonidine 0.2 mg (group C)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Tramadol 100 mg (group T)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Pregabalin 150 mg (group P)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (group O)
Number of subjects: 120
Study: 34210732

Group type: EXPERIMENTAL
Intervention: Sigmoidoscopy
Number of subjects: 42554

Group type: EXPERIMENTAL
Intervention: Colonoscopy after positive FIT
Number of subjects: 42554
Study: 33977835

Group type: EXPERIMENTAL
Intervention: Initial Partial ROM (100°‐65°)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Final Partial ROM (65°‐30°)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Full ROM (100°‐30°)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Varied ROM (daily alternation between INITIALROM and FINALROM)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (non-training control)
Number of subjects: 45
Study: 34478028

Group type: EXPERIMENTAL
Intervention: IV milrinone (0.5 µg/kg/min, median duration of infusion 5 days)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: IV milrinone
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control (hypertension alone)
Number of subjects: 94
Study: 35716937

Group type: EXPERIMENTAL
Intervention: 4D flow automated dynamic method
Number of subjects: 50

Group type: COMPARATOR
Intervention: Static planar method
Number of subjects: 50
Study: 33236687

Group type: EXPERIMENTAL
Intervention: Tubridge flow diverter (FD)
Number of subjects: 200
Study: 34996347

Group type: EXPERIMENTAL
Intervention: WBF-011 (5-strain novel probiotic formulation)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 104
Study: 35586668

Group type: EXPERIMENTAL
Intervention: PD-1/PD-L1 inhibitor chemotherapy combined with Lung Cancer Fang No. 1 treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: PD-1/PD-L1 inhibitor chemotherapy
Number of subjects: 80
Study: 34255269

Group type: EXPERIMENTAL
Intervention: HD–EAM group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Merge group
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 37013726

Group type: EXPERIMENTAL
Intervention: Short dermoscopy e‐learning course (4 h) with mandatory refreshers
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Short dermoscopy e‐learning course (4 h) with optional refreshers
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Long dermoscopy training course (12 h) with mandatory refreshers
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Long dermoscopy training course (12 h) with optional refreshers
Number of subjects: 233
Study: 33606920

Group type: EXPERIMENTAL
Intervention: Moderate eGFR variability (>6.4 to ≤12.1)
Number of subjects: 8241

Group type: EXPERIMENTAL
Intervention: High eGFR variability (>12.1)
Number of subjects: 8241

Group type: COMPARATOR
Intervention: Low eGFR variability (≤6.4)
Number of subjects: 8241
Study: 36315349

Group type: EXPERIMENTAL
Intervention: Direct Oral Anticoagulants (DOACs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low Molecular Weight Heparins (LMWHs)
Number of subjects: 0
Study: 33691772

Group type: EXPERIMENTAL
Intervention: Integrated Behavioral Health (IBH) intervention including a 24-month supported practice change process, online curriculum, practice redesign workbook, remote quality improvement coaching, and online learning community.
Number of subjects: 3375

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 3375
Study: 32761445

Group type: EXPERIMENTAL
Intervention: Oral leukoplakia cases with etiological factors (smoking, alcohol consumption)
Number of subjects: 107
Study: 36262763

Group type: EXPERIMENTAL
Intervention: Dialectical Behavioral Therapy (DBT)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 210
Study: 34847898

Group type: EXPERIMENTAL
Intervention: Desensitizing dentifrice containing CPP
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Desensitizing dentifrice containing PVM/MA
Number of subjects: 33

Group type: COMPARATOR
Intervention: Regular toothpaste (Control)
Number of subjects: 33
Study: 32617646

Group type: EXPERIMENTAL
Intervention: tolcapone (100 mg TID for 5 days)
Number of subjects: 55
Study: 35715930

Group type: EXPERIMENTAL
Intervention: Early amyloid-PET (ARM1)
Number of subjects: 840

Group type: EXPERIMENTAL
Intervention: Late amyloid-PET (ARM2)
Number of subjects: 840

Group type: EXPERIMENTAL
Intervention: Free-choice (ARM3)
Number of subjects: 840
Study: 32232608

Group type: EXPERIMENTAL
Intervention: Unilateral incremental VOR adaptation training (10 sessions over 12 days)
Number of subjects: 10
Study: 34609084

Group type: EXPERIMENTAL
Intervention: Pain neuroscience education (PNE)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pharmacological treatment
Number of subjects: 40
Study: 32182235

Group type: EXPERIMENTAL
Intervention: ARSER
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: empirical‐JTK
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GeneCycle
Number of subjects: 0

Group type: COMPARATOR
Intervention: naive method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lomb Scargle
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RAIN
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: JTK
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: meta2d
Number of subjects: 0
Study: 34408396

Group type: EXPERIMENTAL
Intervention: Imaging Only group
Number of subjects: 66

Group type: COMPARATOR
Intervention: Full Exam group
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 66
Study: 33025146

Group type: EXPERIMENTAL
Intervention: Surgical guide made using cone beam computed tomography (CBCT) and dental cast (Group I)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgical guide made using only CBCT data (Group II)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No surgical guide (Group III)
Number of subjects: 0